Final opportunity to join our free 1-hour microbiome session tomorrow! 📌 Learn the latest in microbiome science and therapeutics. 📌 Network with professionals. 📌 Engage in Q&A for personalised insights. 🔗 Register here: hubs.la/Q02BTVhd0 #OGImmuno

NHS England aims to match up to 10,000 cancer patients to suitable personalised cancer vaccine clinical trials by 2030. hubs.la/Q02CdvTN0 📰 For monthly updates in immuno-oncology, sign up for our monthly newsletter here for the latest: hubs.la/Q02CdrfD0

Our Microbiome Drug Development Online Symposium will bring together key opinion leaders from across the globe for focused discussions on microbiome discovery and therapeutic development✨ 📅 24th September 2024 📍 Online 🎟️ Book now: hubs.la/Q02Fc_9_0 #OGImmuno

🗞️ Stay at the forefront of immuno-oncology! Subscribe to our monthly newsletter and be the first to receive exclusive insights, in-depth market analyses, and expert articles delivered directly to your inbox. hubs.la/Q02FfYVy0 #OGImmuno

This is big news for the study of immunology! The breakthrough in mouse models will allow researchers to study the human immune system in far greater detail at a far greater pace. hubs.la/Q02G0GQX0

Have you subscribed to our Immuno newsletter yet? Stay updated in the world of immuno-oncology with exclusive insights, in-depth market analyses, and expert articles directly to your inbox 📫✨ Sign up here: hubs.la/Q02GcncD0 #OGImmuno

.PixelgenTech are pioneering spatial proteomics for single cells, and will be available to connect with at #ImmunoUS24! 🧬 View details: hubs.ly/Q02GnHP90 #OGImmuno

🖥️ Now on demand! Mo Jain, MD PhD and Jonathan Usuka from Sapient explore ground-breaking innovations expanding the druggable space and enhancing the discovery of novel targets. Watch here: hubs.la/Q02GVMHQ0 #TargetIdentification #TargetValidation #ProteinTargets

Stay Ahead in Immuno-Oncology! Have you subscribed to our Immuno newsletter yet? Get the latest breakthroughs, in-depth market insights, and expert articles delivered straight to your inbox! 📩 Sign up! hubs.la/Q02LxPkC0 #OGImmuno #ImmunoOncology #Biotech #ClinicalTrials

Looking forward to #ImmunoUS2024? 🌟 This year, dive into the latest in immune-targeting breakthroughs—from cell & gene therapies to therapeutic antibodies, vaccines, and more! 🔍 Discover the full details: hubs.la/Q02LxPpp0 #Immunotherapy #Biotech #ClinicalTrials

Excited to have PixelgenTech joining us at #ImmunoUS2024 as a bronze sponsor! They are revolutionizing our spatial understanding of biology by mapping cell surface proteins. Don't miss out, register now: hubs.la/Q02Lyhy10 #OGImmuno #SpatialBiology #CellMapping

Thrilled to have GemPharmatech as a Gold Sponsor for #ImmunoUS2024! A global leader in #biotech, specializing in humanized animal models and offering full services in model customization, breeding, #phenotyping, and pharmacology. See you in San Diego! ➡️ hubs.la/Q02LyvGR0

🎙️ Excited for the Microbiome Drug Development Online Symposium on Sept 24, 2024! 🌐 Join global innovators & thought leaders from pharma, biotech, academia. 📅 Save the date: hubs.la/Q02MkxbG0 #Microbiome #DrugDevelopment #OnlineSymposium #Biotechnology

The approval means that the bispecific antibody odronextamab can be used to treat adult patients with relapsed or refractory follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) in the EU. hubs.la/Q02N1PSq0

Unlock the Future of Immuno-Oncology! Sign up for our monthly newsletter and dive into exclusive insights, market analyses, and expert articles—all delivered straight to your inbox. 🎉 Subscribe today! hubs.la/Q02LxPs90 #OGImmuno #Biotech #CancerResearch #MedTech

🎙️ Exciting news! We've added more speakers to the Microbiome Drug Development Online Symposium on Sept 24, 2024! 🌐 Join key opinion leaders from UCL and Piton Therapeutics 📅 Save the date! ➡️ hubs.la/Q02Mkx6r0 #Microbiome #DrugDevelopment #Innovation

Struggling with bispecific #antibodyproduction? Join our FREE 1-hour webinar on Oct 2nd at 2pm BST | 9am EST! Dr. Jiansheng Wu (WuXi Biologics) will share strategies to optimize bsAb pairing & scalability. 👉 Register: hubs.la/Q02NjLDk0 #Biologics #Biotechnology

Excited to welcome SGS as a Network & Programme Sponsor for #ImmunoUS2024! SGS is the world’s leading testing, inspection & certification company, recognized globally as the benchmark for #sustainability, quality & integrity. Meet them in San Diego: hubs.la/Q02Lyjgf0

Insilico Medicine and Inimmune Pen Collaboration for AI-Powered Immunotherapy Discovery The two biotechs are working together to overcome specific hurdles in the immunotherapy drug discovery process. hubs.la/Q02Pkk9F0

The researchers analysed high-resolution genomic information from over 1,200 babies and identified three pioneer bacteria that drive the development of the gut microbiota. hubs.la/Q02Pw3p60